Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Axios on MSN
Longevity medicine's do-or-die moment
The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...
Researchers are decoding how signals move between body and brain, with implications for how we understand and treat ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Now he has a company that is trying to change the way we think about the so-called dark genome or noncoding DNA. Previously ...
A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...
Xu and colleagues used partial OSKM reprogramming in aged mice to drive cell-type proportions of the subventricular zone to more youthful levels, which equates to qualified rejuvenation of a ...
Pluristyx, a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, today announced the Japanese Patent Office (JPO) issued a ...
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...
A new way of reprogramming our immune cells to shrink or kill off cancer cells has been shown to work in the otherwise hard to treat and devastating skin cancer, melanoma. The University of ...
Researchers at PSI and ETH Zurich have taken connective tissue cells that have been mechanically reprogrammed to resemble stem cells and transplanted them into damaged skin. In their laboratory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results